A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton, +8

Pediatric Blood & Cancer

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)

Patrick A. Thompson, Rachid Drissi, Jodi A. Muscal, +8

Clinical Cancer Research

Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates

Jodi A. Muscal, Yongkai Sun, Jed G. Nuchtern, +4

Cancer Chemotherapy and Pharmacology

Pharmacological StudyMedicineCerebrospinal FluidNeuropharmacologyPharmacotherapy +5

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis

Yongfeng Wang, Long Wang, Shan Guan, +18

Scientific Reports

Mucoepidermoid Carcinoma in Children: A Single Institutional Experience

Piti Techavichit, John Hicks, Dolores López‐Terrada, +9

Pediatric Blood & Cancer

Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines

Jodi A. Muscal, Kathleen A. Scorsone, Linna Zhang, +2

Investigational New Drugs

Hematological MalignancyNeuro-oncologyMedicineMalignant Blood DisorderPharmacology +6

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model

Jiaxiong Lu, Shan Guan, Yanling Zhao, +14

Cancer Letters

MedicineCell DeathInhibits Tumor GrowthAnti-cancer AgentTumor Suppressor +5

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Shayahati Bieerkehazhi, Zhenghu Chen, Yanling Zhao, +13

Oncotarget

Nb Cell ProliferationMedicineNeuroblastoma GrowthReceptor Tyrosine KinaseCancer Cell Biology +10

Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models

Mari Kogiso, Lin Qi, Frank Braun, +15

Clinical Cancer Research

Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates

Jodi A. Muscal, Patrick A. Thompson, Vincent L. Giranda, +9

Cancer Chemotherapy and Pharmacology

MedicineCerebrospinal FluidOral AdministrationPharmacotherapyClinical Chemistry +5